Published in Proc Natl Acad Sci U S A on December 01, 1979
The genomic and epidemiological dynamics of human influenza A virus. Nature (2008) 10.26
Discriminant analysis of principal components: a new method for the analysis of genetically structured populations. BMC Genet (2010) 7.67
Whole-genome analysis of human influenza A virus reveals multiple persistent lineages and reassortment among recent H3N2 viruses. PLoS Biol (2005) 5.48
Cloning of influenza cDNA ino M13: the sequence of the RNA segment encoding the A/PR/8/34 matrix protein. Nucleic Acids Res (1980) 4.75
The evolution of human influenza viruses. Philos Trans R Soc Lond B Biol Sci (2001) 4.74
Pandemic threat posed by avian influenza A viruses. Clin Microbiol Rev (2001) 3.33
Multiple reassortment events in the evolutionary history of H1N1 influenza A virus since 1918. PLoS Pathog (2008) 3.25
A revision of the system of nomenclature for influenza viruses: a WHO memorandum. Bull World Health Organ (1980) 2.86
Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains. Nucleic Acids Res (1980) 2.25
Sporadic occurrence of zoonotic swine influenza virus infections. J Clin Microbiol (1984) 2.24
Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.19
Antigenic variation of influenza A virus nucleoprotein detected with monoclonal antibodies. J Virol (1980) 2.00
Laboratory-based surveillance of influenza A(H1N1) and A(H3N2) viruses in 1980-81: antigenic and genomic analyses. Bull World Health Organ (1983) 1.89
One influenza virus particle packages eight unique viral RNAs as shown by FISH analysis. Proc Natl Acad Sci U S A (2012) 1.61
Antigenic and genomic analyses of influenza A(H1N1) viruses from different regions of the world, February 1978 to March 1980. Infect Immun (1981) 1.55
Analysis of reassortment of genome segments in mice mixedly infected with rotaviruses SA11 and RRV. J Virol (1986) 1.54
Novel genotypes of H9N2 influenza A viruses isolated from poultry in Pakistan containing NS genes similar to highly pathogenic H7N3 and H5N1 viruses. PLoS One (2009) 1.53
Antigenic and genetic variation in influenza A (H1N1) virus isolates recovered from a persistently infected immunodeficient child. J Virol (1991) 1.47
Sequential mutations in the NS genes of influenza virus field strains. J Virol (1983) 1.44
Sequence diversity in S1 genes and S1 translation products of 11 serotype 3 reovirus strains. J Virol (1990) 1.44
Analysis of an influenza A virus mutant with a deletion in the NS segment. J Virol (1984) 1.42
Matrix gene of influenza a viruses isolated from wild aquatic birds: ecology and emergence of influenza a viruses. J Virol (2004) 1.41
A new concept of the epidemic process of influenza A virus. Epidemiol Infect (1987) 1.29
Evolution of the Hong Kong influenza A sub-type. Structural relationships between the haemagglutinin from A/duck/Ukraine/1/63 (Hav 7) and the Hong Kong (H3) haemagglutinins. Biochem J (1981) 1.20
Expression of the three influenza virus polymerase proteins in a single cell allows growth complementation of viral mutants. Proc Natl Acad Sci U S A (1986) 1.20
Direct isolation of H1N2 recombinant virus from a throat swab of a patient simultaneously infected with H1N1 and H3N2 influenza A viruses. J Clin Microbiol (1983) 1.12
The new influenza A H1N1 virus: balancing on the interface of humans and animals. Can Vet J (2010) 1.12
Influenza AH1N2 viruses, United Kingdom, 2001-02 influenza season. Emerg Infect Dis (2003) 1.10
Seroepidemiology of H1N1 influenza: the infection and re-infection rate in winter 1978-79. J Hyg (Lond) (1981) 0.94
The return of the historic influenza A H1N1 virus and its impact on the population of the United Kingdom. J Hyg (Lond) (1982) 0.92
Influenza C virus RNA 7 codes for a nonstructural protein. J Virol (1985) 0.87
Genetic variants of influenza A/Taiwan/1/86 cocirculating in Canada during the winter of 1986 to 1987. J Clin Microbiol (1988) 0.86
Recent contributions of molecular biology to the clinical virology of myxoviruses. Yale J Biol Med (1980) 0.85
Genetic variation in swine influenza virus A isolate associated with proliferative and necrotizing pneumonia in pigs. J Clin Microbiol (1994) 0.81
Spatiotemporal dynamics in the early stages of the 2009 A/H1N1 influenza pandemic. PLoS Curr (2009) 0.81
Antigenic analysis of H1N1 viruses isolated in the Houston metropolitan area during four successive seasons. Infect Immun (1983) 0.81
Surveillance in Eastern India (2007-2009) revealed reassortment event involving NS and PB1-F2 gene segments among co-circulating influenza A subtypes. Virol J (2012) 0.78
Viral respiratory diseases: vaccines and antivirals. Bull World Health Organ (1981) 0.77
Hantaviral Proteins: Structure, Functions, and Role in Hantavirus Infection. Front Microbiol (2015) 0.76
Pandemism of swine flu and its prospective drug therapy. Eur J Clin Microbiol Infect Dis (2012) 0.76
Frequency of influenza H3N2 intra-subtype reassortment: attributes and implications of reassortant spread. BMC Biol (2016) 0.75
An in vitro fluorescence based study of initiation of RNA synthesis by influenza B polymerase. Nucleic Acids Res (2017) 0.75
Peptide mapping by limited proteolysis in sodium dodecyl sulfate and analysis by gel electrophoresis. J Biol Chem (1977) 72.51
On the origin of the human influenza virus subtypes H2N2 and H3N2. Virology (1978) 9.02
Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature (1978) 5.43
Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes. Proc Natl Acad Sci U S A (1976) 3.19
RNAs of influenza A, B, and C viruses. J Virol (1976) 3.10
Replication and plaque assay of influenza virus in an established line of canine kidney cells. Appl Microbiol (1968) 3.04
Mapping of the influenza virus genome. III. Identification of genes coding for nucleoprotein, membrane protein, and nonstructural protein. J Virol (1976) 2.73
Genetic relatedness between the new 1977 epidemic strains (H1N1) of influenza and human influenza strains isolated between 1947 and 1957 (H1N1). Virology (1978) 2.51
A micromethod for detailed characterization of high molecular weight RNA. Methods Enzymol (1980) 2.36
P1 and P3 proteins of influenza virus are required for complementary RNA synthesis. J Virol (1977) 2.19
Ecology of influenza viruses in lower mammals and birds. Br Med Bull (1979) 1.92
A new avian influenza virus from feral birds in the USSR: recombination in nature? Bull World Health Organ (1974) 1.88
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci U S A (1978) 1.86
Evolution of human influenza A viruses in nature: sequential mutations in the genomes of new H1N1. Cell (1979) 1.68
Selection and identification of influenza virus recombinants of defined genetic composition. J Virol (1976) 1.54
Influenza B virus genome: assignment of viral polypeptides to RNA segments. J Virol (1979) 1.43
Crystallization and peptide maps of neuraminidase "heads" from H2N2 and H3N2 influenza virus strains. Virology (1978) 1.31
Difference in protein patterns of influenza A viruses. Virology (1977) 1.30
Isolation of three different influenza A viruses from an individual after probable double infection with H3N2 and H1N1 viruses. Jpn J Med Sci Biol (1979) 1.27
New use of BCG for recombinant vaccines. Nature (1991) 14.40
Rescue of influenza A virus from recombinant DNA. J Virol (1999) 11.54
Amplification, expression, and packaging of foreign gene by influenza virus. Cell (1989) 11.21
A novel influenza A virus mitochondrial protein that induces cell death. Nat Med (2001) 9.90
Influenza A virus lacking the NS1 gene replicates in interferon-deficient systems. Virology (1998) 9.81
Introduction of site-specific mutations into the genome of influenza virus. Proc Natl Acad Sci U S A (1990) 7.68
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase. Virology (1974) 6.53
Activation of interferon regulatory factor 3 is inhibited by the influenza A virus NS1 protein. J Virol (2000) 6.22
Promoter analysis of influenza virus RNA polymerase. J Virol (1989) 5.66
The Ebola virus VP35 protein functions as a type I IFN antagonist. Proc Natl Acad Sci U S A (2000) 5.46
Influenza A virus NS1 protein prevents activation of NF-kappaB and induction of alpha/beta interferon. J Virol (2000) 5.44
Recent human influenza A (H1N1) viruses are closely related genetically to strains isolated in 1950. Nature (1978) 5.43
The 3' and 5'-terminal sequences of influenza A, B and C virus RNA segments are highly conserved and show partial inverted complementarity. Gene (1980) 5.08
The genes of influenza virus. Cell (1977) 5.05
Sequence of the 1918 pandemic influenza virus nonstructural gene (NS) segment and characterization of recombinant viruses bearing the 1918 NS genes. Proc Natl Acad Sci U S A (2001) 4.93
Positive Darwinian evolution in human influenza A viruses. Proc Natl Acad Sci U S A (1991) 4.78
Differences in RNA patterns of influenza A viruses. J Virol (1976) 4.68
Evolution of human influenza A viruses over 50 years: rapid, uniform rate of change in NS gene. Science (1986) 4.64
Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells. J Virol (1977) 4.52
Determination of influenza virus proteins required for genome replication. J Virol (1990) 4.36
High-efficiency formation of influenza virus transfectants. J Virol (1991) 4.34
A plasmid-based reverse genetics system for influenza A virus. J Virol (1996) 4.33
Genomic RNAs of influenza viruses are held in a circular conformation in virions and in infected cells by a terminal panhandle. Proc Natl Acad Sci U S A (1987) 4.31
Measurement of the mutation rates of animal viruses: influenza A virus and poliovirus type 1. J Virol (1986) 4.15
Influenza B virus evolution: co-circulating lineages and comparison of evolutionary pattern with those of influenza A and C viruses. Virology (1988) 4.03
The influenza virus NEP (NS2 protein) mediates the nuclear export of viral ribonucleoproteins. EMBO J (1998) 3.98
Influenza A and B viruses expressing altered NS1 proteins: A vaccine approach. Proc Natl Acad Sci U S A (2000) 3.95
A proline-rich motif within the matrix protein of vesicular stomatitis virus and rabies virus interacts with WW domains of cellular proteins: implications for viral budding. J Virol (1999) 3.92
Development of a humanized monoclonal antibody (MEDI-493) with potent in vitro and in vivo activity against respiratory syncytial virus. J Infect Dis (1997) 3.88
The polyadenylation signal of influenza virus RNA involves a stretch of uridines followed by the RNA duplex of the panhandle structure. J Virol (1991) 3.85
Influenza virus NS1 protein counteracts PKR-mediated inhibition of replication. J Virol (2000) 3.77
Inhibition of influenza virus replication in tissue culture by 2-deoxy-2,3-dehydro-N-trifluoroacetylneuraminic acid (FANA): mechanism of action. J Gen Virol (1976) 3.61
Synthesis and cellular location of the ten influenza polypeptides individually expressed by recombinant vaccinia viruses. Virology (1987) 3.53
Cross-neutralizing activity against divergent human immunodeficiency virus type 1 isolates induced by the gp41 sequence ELDKWAS. J Virol (1994) 3.49
Mapping of the influenza virus genome: identification of the hemagglutinin and the neuraminidase genes. Proc Natl Acad Sci U S A (1976) 3.19
RNAs of influenza A, B, and C viruses. J Virol (1976) 3.10
Safety and efficacy of a recombinant DNA Plasmodium falciparum sporozoite vaccine. Lancet (1987) 2.98
Protective immunity elicited by recombinant bacille Calmette-Guerin (BCG) expressing outer surface protein A (OspA) lipoprotein: a candidate Lyme disease vaccine. J Exp Med (1993) 2.96
Late domain function identified in the vesicular stomatitis virus M protein by use of rhabdovirus-retrovirus chimeras. J Virol (1999) 2.90
The role of interferon in influenza virus tissue tropism. J Virol (1998) 2.88
Evolution of influenza A and B viruses: conservation of structural features in the hemagglutinin genes. Proc Natl Acad Sci U S A (1982) 2.86
Variation of influenza A, B, and C viruses. Science (1982) 2.75
NPI-1, the human homolog of SRP-1, interacts with influenza virus nucleoprotein. Virology (1995) 2.74
Mapping of the influenza virus genome. III. Identification of genes coding for nucleoprotein, membrane protein, and nonstructural protein. J Virol (1976) 2.73
Temperature-sensitive mutants of influenza WSN virus defective in virus-specific RNA synthesis. J Virol (1975) 2.72
Recombinant Newcastle disease virus as a vaccine vector. J Virol (2001) 2.67
An influenza virus containing nine different RNA segments. Virology (1991) 2.66
An influenza A virus containing influenza B virus 5' and 3' noncoding regions on the neuraminidase gene is attenuated in mice. Proc Natl Acad Sci U S A (1991) 2.55
The NPI-1/NPI-3 (karyopherin alpha) binding site on the influenza a virus nucleoprotein NP is a nonconventional nuclear localization signal. J Virol (1997) 2.51
Expression of Plasmodium falciparum circumsporozoite proteins in Escherichia coli for potential use in a human malaria vaccine. Science (1985) 2.44
Priming with recombinant influenza virus followed by administration of recombinant vaccinia virus induces CD8+ T-cell-mediated protective immunity against malaria. Proc Natl Acad Sci U S A (1993) 2.44
Geographic variation in breast cancer mortality in the United States: a hypothesis involving exposure to solar radiation. Prev Med (1990) 2.41
Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus. J Virol (1993) 2.40
Two nuclear location signals in the influenza virus NS1 nonstructural protein. J Virol (1988) 2.34
Cellular splicing factor RAF-2p48/NPI-5/BAT1/UAP56 interacts with the influenza virus nucleoprotein and enhances viral RNA synthesis. J Virol (2001) 2.33
Preparation of influenza virus subviral particles lacking the HA1 subunit of hemagglutinin: unmasking of cross-reactive HA2 determinants. Virology (1983) 2.32
Expression of a foreign protein by influenza A virus. J Virol (1994) 2.28
Plasmid-only rescue of influenza A virus vaccine candidates. Philos Trans R Soc Lond B Biol Sci (2001) 2.28
Complete nucleotide sequence of the influenza A/PR/8/34 virus NS gene and comparison with the NS genes of the A/Udorn/72 and A/FPV/Rostock/34 strains. Nucleic Acids Res (1980) 2.25
Human and bovine coronaviruses recognize sialic acid-containing receptors similar to those of influenza C viruses. Proc Natl Acad Sci U S A (1988) 2.24
Sporadic occurrence of zoonotic swine influenza virus infections. J Clin Microbiol (1984) 2.24
Efficient expression of influenza virus NS1 nonstructural proteins in Escherichia coli. Proc Natl Acad Sci U S A (1983) 2.19
P1 and P3 proteins of influenza virus are required for complementary RNA synthesis. J Virol (1977) 2.19
Isolation and characterization of influenza virus recombinants with high and low neuraminidase activity. Use of 2-(3'-methoxyphenyl)-n-acetylneuraminic acid to identify cloned populations. Virology (1974) 2.19
Alterations of the stalk of the influenza virus neuraminidase: deletions and insertions. Virus Res (1993) 2.12
Gene composition of high-yielding influenza vaccine strains obtained by recombination. J Infect Dis (1980) 2.11
Oral Salmonella typhimurium vaccine expressing circumsporozoite protein protects against malaria. Science (1988) 2.09
Characterization of the polyadenylation signal of influenza virus RNA. J Virol (1994) 2.09
Nonconserved nucleotides at the 3' and 5' ends of an influenza A virus RNA play an important role in viral RNA replication. Virology (1996) 2.03
Determination of CYP1A2 and NAT2 phenotypes in human populations by analysis of caffeine urinary metabolites. Pharmacogenetics (1992) 2.02
Mutational analysis of the promoter required for influenza virus virion RNA synthesis. J Virol (1992) 2.01
Nuclear import of influenza virus RNA can be mediated by viral nucleoprotein and transport factors required for protein import. J Biol Chem (1995) 2.00
Mutational analysis of the influenza virus vRNA promoter. Virus Res (1993) 1.99
Susceptibility of influenza A viruses to amantadine is influenced by the gene coding for M protein. J Virol (1978) 1.99
Inhibition of neuraminidase activity by derivatives of 2-deoxy-2,3-dehydro-N-acetylneuraminic acid. Virology (1974) 1.94
Sequential mutations in hemagglutinins of influenza B virus isolates: definition of antigenic domains. Proc Natl Acad Sci U S A (1983) 1.88
Influenza A virus transfectants with chimeric hemagglutinins containing epitopes from different subtypes. J Virol (1992) 1.88
Biochemical evidence that "new" influenza virus strains in nature may arise by recombination (reassortment). Proc Natl Acad Sci U S A (1978) 1.86
NS1-Binding protein (NS1-BP): a novel human protein that interacts with the influenza A virus nonstructural NS1 protein is relocalized in the nuclei of infected cells. J Virol (1998) 1.77
Determination of the mutation rate of a retrovirus. J Virol (1988) 1.75
Comparison of the three large polymerase proteins of influenza A, B, and C viruses. Virology (1989) 1.72
Chimeric influenza virus induces neutralizing antibodies and cytotoxic T cells against human immunodeficiency virus type 1. J Virol (1993) 1.70
Effect of parsley (Petroselinum crispum) intake on urinary apigenin excretion, blood antioxidant enzymes and biomarkers for oxidative stress in human subjects. Br J Nutr (1999) 1.70
Evolution of human influenza A viruses in nature: sequential mutations in the genomes of new H1N1. Cell (1979) 1.68
Infectious influenza A and B virus variants with long carboxyl terminal deletions in the NS1 polypeptides. Virology (1987) 1.68
Epidemiology of influenza C virus in man: multiple evolutionary lineages and low rate of change. Virology (1986) 1.67
Genetic manipulation of negative-strand RNA virus genomes. Annu Rev Microbiol (1993) 1.66
Rat ATP citrate-lyase. Molecular cloning and sequence analysis of a full-length cDNA and mRNA abundance as a function of diet, organ, and age. J Biol Chem (1990) 1.64
Attenuation of influenza A virus mRNA levels by promoter mutations. J Virol (1998) 1.63
The E3 protein of bovine coronavirus is a receptor-destroying enzyme with acetylesterase activity. J Virol (1988) 1.60
Mapping of the influenza virus genome. II. Identification of the P1, P2, and P3 genes. Virology (1977) 1.60
Antigenic variants of influenza viruses: marked differences in the frequencies of variants selected with different monoclonal antibodies. Virology (1980) 1.59